Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma.

Plantinga TS, Costantini I, Heinhuis B, Huijbers A, Semango G, Kusters B, Netea MG, Hermus AR, Smit JW, Dinarello CA, Joosten LA, Netea-Maier RT.

Carcinogenesis. 2013 Jul;34(7):1529-35. doi: 10.1093/carcin/bgt092. Epub 2013 Mar 13.

PMID:
23486016
2.

Interleukin (IL)-21 promoter polymorphism increases the risk of thyroid cancer in Chinese population.

Xiao M, Hu S, Tang J, Zhang L, Jiang H.

Gene. 2014 Mar 1;537(1):15-9. doi: 10.1016/j.gene.2013.12.050. Epub 2013 Dec 31.

PMID:
24389496
3.

Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.

Çil E, Kumral A, Kanmaz-Özer M, Vural P, Doğru-Abbasoğlu S, Altuntaş Y, Uysal M.

Mol Biol Rep. 2014 May;41(5):3091-7. doi: 10.1007/s11033-014-3169-7. Epub 2014 Jan 28.

PMID:
24464184
4.

Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness.

Snoussi K, Mahfoudh W, Bouaouina N, Fekih M, Khairi H, Helal AN, Chouchane L.

BMC Cancer. 2010 Jun 12;10:283. doi: 10.1186/1471-2407-10-283.

5.

The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population.

Lee WP, Tai DI, Lan KH, Li AF, Hsu HC, Lin EJ, Lin YP, Sheu ML, Li CP, Chang FY, Chao Y, Yen SH, Lee SD.

Clin Cancer Res. 2005 Sep 15;11(18):6431-41.

6.

Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility.

Stanilova SA, Miteva LD, Karakolev ZT, Stefanov CS.

Intensive Care Med. 2006 Feb;32(2):260-6. Epub 2006 Jan 25.

PMID:
16435103
7.

A proinflammatory cytokine interleukin-32beta promotes the production of an anti-inflammatory cytokine interleukin-10.

Kang JW, Choi SC, Cho MC, Kim HJ, Kim JH, Lim JS, Kim SH, Han JY, Yoon DY.

Immunology. 2009 Sep;128(1 Suppl):e532-40. doi: 10.1111/j.1365-2567.2008.03025.x. Epub 2008 Dec 18.

8.

Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer.

Bushley AW, Ferrell R, McDuffie K, Terada KY, Carney ME, Thompson PJ, Wilkens LR, Tung KH, Ness RB, Goodman MT.

Gynecol Oncol. 2004 Dec;95(3):672-9.

PMID:
15581980
9.

Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.

Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP, Schrumpf E, Chapman RW; European Study Group of Primary Sclerosing Cholangitis..

Gut. 2001 Aug;49(2):288-94.

10.

Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan.

Taguchi A, Ohmiya N, Shirai K, Mabuchi N, Itoh A, Hirooka Y, Niwa Y, Goto H.

Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2487-93.

11.

Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.

Babar M, Ryan AW, Anderson LA, Segurado R, Turner G, Murray LJ, Murphy SJ, Johnston BT, Comber H, Reynolds JV, McManus R.

Am J Gastroenterol. 2012 Sep;107(9):1331-41. doi: 10.1038/ajg.2012.134. Epub 2012 Jun 5.

PMID:
22664470
12.

The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults.

Kilpinen S, Hulkkonen J, Wang XY, Hurme M.

Eur Cytokine Netw. 2001 Mar;12(1):62-8.

13.

Association of the IL12RB1 promoter polymorphisms with increased risk of atopic dermatitis and other allergic phenotypes.

Takahashi N, Akahoshi M, Matsuda A, Ebe K, Inomata N, Obara K, Hirota T, Nakashima K, Shimizu M, Tamari M, Doi S, Miyatake A, Enomoto T, Nakashima H, Ikezawa Z, Shirakawa T.

Hum Mol Genet. 2005 Nov 1;14(21):3149-59. Epub 2005 Sep 13.

PMID:
16159888
14.

Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.

Farjadfar A, Mojtahedi Z, Ghayumi MA, Erfani N, Haghshenas MR, Ghaderi A.

Acta Oncol. 2009;48(7):971-6. doi: 10.1080/02841860902878145.

PMID:
19642044
15.

Role of cytokine gene polymorphisms in gastric cancer risk in Chile.

Gonzalez-Hormazabal P, Musleh M, Bustamante M, Stambuk J, Escandar S, Valladares H, Lanzarini E, Chiong H, Rojas J, Castro VG, Rubio-Reyes C, Jara L, Berger Z.

Anticancer Res. 2014 Jul;34(7):3523-30.

PMID:
24982364
16.

Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma.

Vairaktaris E, Yapijakis C, Serefoglou Z, Avgoustidis D, Critselis E, Spyridonidou S, Vylliotis A, Derka S, Vassiliou S, Nkenke E, Patsouris E.

J Cancer Res Clin Oncol. 2008 Aug;134(8):821-32. doi: 10.1007/s00432-008-0360-z. Epub 2008 Feb 14.

PMID:
18273643
17.

Association of susceptibility to brucellosis and interleukin-4 promoter polymorphism.

Rezazadeh M, Hajilooi M, Haidari M, Rafiei A, Alavi SA, Keramat F.

Scand J Infect Dis. 2006;38(11-12):1045-9.

PMID:
17148075
18.

Gene-gene interaction between interleukin-4 and interleukin-4 receptor alpha in Korean children with asthma.

Lee SG, Kim BS, Kim JH, Lee SY, Choi SO, Shim JY, Hong TJ, Hong SJ.

Clin Exp Allergy. 2004 Aug;34(8):1202-8.

PMID:
15298559
19.

Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines.

Heinhuis B, Plantinga TS, Semango G, Küsters B, Netea MG, Dinarello CA, Smit JW, Netea-Maier RT, Joosten LA.

Carcinogenesis. 2016 Feb;37(2):197-205. doi: 10.1093/carcin/bgv172. Epub 2015 Dec 17.

PMID:
26678222
20.

Proinflammatory cytokine gene polymorphisms among Hashimoto's thyroiditis patients.

Chen RH, Chang CT, Chen WC, Tsai CH, Tsai FJ.

J Clin Lab Anal. 2006;20(6):260-5.

PMID:
17115419

Supplemental Content

Support Center